Pharming Group N.V.

PHAR chart

Pharming Group N.V. news

• Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London

  Yahoo Finance · Nov 11, 2:00 AM EST

• Pharming's executives will take questions in London on Nov. 18. A webcast and replay will be available.

  Stock Titan · Nov 11, 2:00 AM EST

• MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.

  Yahoo Finance · Nov 6, 1:00 AM EST

• UK approves the first treatment specifically for eligible children ages 4 to 11 with a rare immune disease.

  Stock Titan · Nov 6, 1:00 AM EST

• Pharming: 3 Key Takeaways for Long-Term Investors

  fool.com · Nov 4, 5:20 PM EST

• Pharming Group (ENXTAM:PHARM) Stock Faces A Q3 Earnings Valuation Gap

  Yahoo Finance · Oct 28, 1:17 AM EDT

• Pharming (PHAR) Q3 2026 Earnings Call Transcript

  fool.com · Oct 27, 1:30 PM EDT

• Pharming Group Q3 Earnings Call Highlights

  marketbeat.com · Oct 27, 11:05 AM EDT

• Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November

  Yahoo Finance · Oct 27, 2:00 AM EDT

• Pharming Group announces third quarter 2026 revenues above market expectations

  Yahoo Finance · Oct 22, 1:00 AM EDT

• Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026

  Yahoo Finance · Oct 14, 2:00 AM EDT

• Pharming announces CEO transition

  Yahoo Finance · Sep 29, 1:00 AM EDT

Pharming Group N.V. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-11-06
• 6-K6-K2026-10-27
• 6-K6-K2026-10-22
• 6-K6-K2026-10-14
• 6-K6-K2026-09-29
• 6-K6-K2026-09-25
• 6-K6-K2026-09-22
• 6-K6-K2026-09-11
• 6-K6-K2026-08-13
• 6-K6-K2026-07-30
• 6-K6-K2026-06-04
• 6-K6-K2026-05-28

About Pharming Group N.V.

Ticker

PHAR (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Leiden, Netherlands

Incorporated in

Netherlands

Fiscal year end

December 31

SEC CIK

1828316

Frequently asked questions